Cite
HARVARD Citation
Kohrt, H. et al. (n.d.). Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1. Journal for immunotherapy of cancer. p. . [Online].